An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy’s Laboratories (DRL), Hyderabad. Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence. Higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients. The drug will be of immense benefit to the people suffering from COVID-19.

Pursuing Prime Minister Shri Narendra Modi’s call for preparedness against the pandemic, DRDO took the initiative of developing anti-COVID therapeutic application of 2-DG. In April 2020, during the first wave of the pandemic, INMAS-DRDO scientists conducted laboratory experiments with the help of Centre for Cellular and Molecular Biology (CCMB), Hyderabad and found that this molecule works effectively against SARS-CoV-2 virus and inhibits the viral growth. Based on these results, Drugs Controller General of India’s (DCGI) Central Drugs Standard Control Organization (CDSCO) permitted Phase-II clinical trial of 2-DG in COVID-19 patients in May 2020.

The DRDO, along with its industry partner DRL, Hyderabad, started the clinical trials to test the safety and efficacy of the drug in COVID-19 patients. In Phase-II trials (including dose ranging) conducted during May to October 2020, the drug was found to be safe in COVID-19 patients and showed significant improvement in their recovery. Phase IIa was conducted in six hospitals and Phase IIb (dose ranging) clinical trial was conducted at 11 hospitals all over the country. Phase-II trial was conducted on 110 patients.

In efficacy trends, the patients treated with 2-DG showed faster symptomatic cure than Standard of Care (SoC) on various endpoints. A significantly favourable trend (2.5 days difference) was seen in terms of the median time to achieving normalisation of specific vital signs parameters when compared to SoC.

Based on successful results, DCGI further permitted the Phase-III clinical trials in November 2020. The Phase-III clinical trial was conducted on 220 patients between December 2020 to March 2021 at 27 COVID hospitals in Delhi, Uttar Pradesh, West Bengal, Gujarat, Rajasthan, Maharashtra, Andhra Pradesh, Telangana, Karnataka and Tamil Nadu. The detailed data of phase-III clinical trial was presented to DCGI. In 2-DG arm, significantly higher proportion of patients improved symptomatically and became free from supplemental oxygen dependence (42% vs 31%) by Day-3 in comparison to SoC, indicating an early relief from Oxygen therapy/dependence.

The similar trend was observed in patients aged more than 65 years. On May 01, 2021, DCGI granted permission for Emergency Use of this drug as adjunct therapy in moderate to severe COVID-19 patients. Being a generic molecule and analogue of glucose, it can be easily produced and made available in plenty in the country.

The drug comes in powder form in sachet, which is taken orally by dissolving it in water. It accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production. Its selective accumulation in virally infected cells makes this drug unique.

In the ongoing second COVID-19 wave, a large number of patients are facing severe oxygen dependency and need hospitalisation. The drug is expected to save precious lives due to the mechanism of operation of the drug in infected cells. This also reduces the hospital stay of COVID-19 patients

70,000 Isolation beds made available by Railways in more than 4400 Covid Care Coaches

In the relentless fight against Covid, the Ministry of Railways are taking rapid action to swiftly move Isolation Coaches to places of demand (made by respective states) mobilising workforce and…

Banks given Liquidity Facility of ₹ 50,000 crore to improve access to Emergency Health Services

The RBI Governor Shri Shaktikanta Das today announced a series of measures to support the nation’s fight against the second wave of COVID-19 infections.

“Alleviating any constraint from…

Approximately 70% more Wheat procured by Government agencies

In the ongoing Rabi Marketing Season (RMS) 2021-22, Government of India is continuing to procure Rabi crops at MSP from farmers as per existing Price Support Scheme.About 28.80 Lakh Wheat farmers…

First consignment of non-basmati rice exports from Paradip port, Odisha flagged off to Vietnam

In a major boost to India’s rice exports potential especially from eastern region, a consignment has been officially flagged off today from the Paradip International Cargo Terminal (PICT), Odisha…

Import of Oxygen Concentrators for personal use included in exempted category list

The Government has included import of oxygen concentrators for personal use, through post, courier or e-commerce portals, in the list of exempted categories, where Customs clearance is sought as…

Cosmic rays propagating through Milky Way

High energy particles are generally lower in number in the cosmic universe. But the excess number of high energy particles of the antimatter counterpart of the electrons…

Railways issue guidelines for Online Payment System for Freight Charges

Tremendous progress in information and communication technology has now made it feasible to introduce Online Payment System through web that is expected to make the process of paying all types of…

Railway waives off charges for Covid testing and diet supplied during Covid related hospitalisation for Non Railway patients

Indian Railway has waived off charges for Covid testing and diet supplied during Covid related hospitalisation for non Railway patients .

It may be notes that Government of India is…

Emergency Financial Powers to Armed Forces to fight COVID-19 surge

Raksha Mantri Shri Rajnath Singh invoked special provisions and granted Emergency Financial Powers to the Armed Forces to empower them and speed up their efforts in tide over the current COVID-19…

Home care tips for managing COVID-19

The Office of the Principal Scientific Adviser to the Government of India has curated information and brought a simple visual reference to manage mild symptoms of COVID-19 at home- "Home care tips…

PM reviews Army’s preparedness & initiatives for Covid management

Chief of Army Staff General MM Naravane called on Prime Minister Narendra Modi today. 

They discussed various initiatives being taken by the Army to help in Covid management.

Electric Tractor Successfully tested by Central Farm Machinery Training & Testing Institute, Budni (MP)

Central Farm Machinery Training & Testing Institute, Budni (MP) has tested the first-ever electric Tractor in the Institute. The institute received the application for an electric tractor…

AYUSH-64 useful in the treatment of mild to moderate COVID-19 infection

In the middle of5 the havoc wreaked by second wave of the pandemic, AYUSH-64 has emerged as a ray of hope for the patients of mild and moderate COVID-19 infection. The scientists of reputed…

CCI approves acquisition by Tata Digital Limited of up to 64.3% of the total share capital of Supermarket Grocery Supplies Private Ltd (SGS) and SGS’ sole control over Innovative Retail Concepts Private Limited

The Competition Commission of India (CCI) approves acquisition by Tata Digital Limited of up to 64.3% of the total share capital of Supermarket Grocery Supplies Private Ltd (SGS) and SGS’ sole…

Easy Re-registration rules for passenger vehicles, while re-locating from one state to another

The Ministry of Road Transport has issued a notification of draft rules, which would make it much easier for those shifting from one state to another to re-register their vehicles. The step comes…

Remdesvir
- Vizag Goverment Support (Fulfils Reqeuests Obtained Upto 12 Noon) +919133896969
C&F Agents and Stockists
Remdesvir (Covifor)
M/s Somnath Medical: +91939310059

Clause 1.5 of Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 prescribes that every Doctor should prescribe drugs with generic names Readable and preferably in capital letters and he/she shall ensure that there is a rational prescription and use of drug.

BLOOD BANKS
Vizag Blood Banks
- NTR Blood Bank, Ramnagar:+918912565858
- Rotary Blood Bank, Jagdamba Plasma Request / Donation

We are all trying hard to succeed in our life.  However, we are not able to find sufficient funds to start a business. Here a list of low investment small business ideas that can help you to succeed in your life 

 

VISAKHAPATNAM COVID -19 HOSPITALS LIST and Contact numbers
 
GOVERNMENT TB-HOSPITAL MOBILE NO: 0891-2552525